课题基金 / 基金详情

DEVELOPMENT OF A 191-OS:191M-IR RADIONUCLIDE GENERATOR

DEVELOPMENT OF A 191-OS:191M-IR RADIONUCLIDE GENERATOR
191-OS:191M-IR 放射性核素发生器的开发
批准号:
3187222
负责人:
ALAN Brent PACKARD
金额:
$8.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-06-01 至 1989-05-31

项目摘要

项目成果

ALAN Brent PACKARD的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The development of the 191Os-191m/Ir generator has, until recently, been based on the systematic evaluation of different combinations of ion-exchange material and eluent while retaining the same chemical form of the osmium-191 parent. While incremental improvements have been realized through this approach, these improvements have not, to date, been dramatic enough to facilitate routine clinical use of 191m/Ir for radionuclide angiocardiography. We have recently demonstrated, however, that much greater improvements in generator performance can be achieved through the use of a different chemical form of the osmium-191 parent. Through the use of dicarboxylic acid complexes of osmium(VI) we have developed generators with 2-3 times higher 191m/Ir yield and one-tenth the 191Os breakthrough of earlier designs. In addition, these are the first 191Os-191m/Ir generators that may be used with a physiologically compatible eluent. These generators still, however, have relatively low 191m/Ir yield (30% mL) and the yield decreases with time as a result of photolysis of the osmium complex. The goal of this project is the development of a new 191Os-191m/Ir generator with higher (and constant) 191m/Ir yield that retains the properties of low 191Os breakthrough and a physiologically compatible eluent of the dicarboxylic acid generators. This goal will be achieved through evaluation of a new series of osmium complexes in lower oxidation states (II, III) than those used in any of the previous designs of the 191Os-191m/Ir generator. Osmium complexes in these lower oxidation states will, after beta decay of 191Os, lead directly to stable iridium complexes that may be eluted in high yield. This approach avoids one of the inherent limitations of 191Os-191m/Ir generators using osmium complexes in higher (IV, VI) oxidation states that offer no direct path to an elutable iridium complex and, at the same time, incorporates the results of our earlier studies showing the improvements in generator performance that may be realized through more appropriate choice of the osmium-191 parent complex.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Image-guided dosimetry-based alpha particle therapy for neuroblastoma.
Image-guided dosimetry-based alpha particle therapy for neuroblastoma.
2014 Metals in Medicine Gordon Research Conference
  • 批准号:
    8710800
  • 项目类别:
  • 资助金额:
    $1.7万
  • 财政年份:
    2014
  • 负责人:
    ALAN Brent PACKARD
  • 依托单位:
A Novel F-18 PET Myocardial Perfusion Radiopharmaceutical based on Rhodamine Dyes
  • 批准号:
    8086347
  • 项目类别:
  • 资助金额:
    $52.22万
  • 财政年份:
    2011
  • 负责人:
    ALAN Brent PACKARD
  • 依托单位: